BioSpace News Archive

Quarterly revenue of $529 million, up 4% over prior year; GAAP EPS of $0.74 and adjusted EPS of $0.81

Tandem Diabetes Care, Inc. announced that the U.S. Food and Drug Administration has classified the t:slim X2™ insulin pump as the first in a new device category called Alternate Controller Enabled Infusion Pumps.

Frelii Inc. today announced that it has appointed two renowned physicians, Anthony R. Torres, M.D. and Susan H. Morelli M.D., to its Scientific Advisory Board.

Home Helpers Home Care has been named Home Care Pulse Endorsed National Provider and Best of Home Care Endorsed National Provider.

Today, the U.S. Food and Drug Administration issued a warning letter to Mark Berman, M.D., of Beverly Hills, California, for illegally marketing an unapproved implantable device, the Pocket Protector, that Dr. Berman claims can prevent and treat a complication of breast implants known as capsular contracture, or tightening of scar tissue.

More than 250 of the nation’s leading health care entrepreneurs and innovators, academics, government officials, cultural ambassadors, sports figures and other thought leaders will explore, discuss and develop solutions to improve global approaches to enhancing wellbeing and health at the 2019 Lake Nona Impact Forum held Feb. 20-22 in Lake Nona, Orlando, Fla.

For the ninth consecutive year, Fortune magazine named St. Jude Children’s Research Hospital to the “100 Best Companies to Work For” list.

Today, Caravan Health announced a groundbreaking new collaboration with community health systems across the country

Clearance strengthens SIG Medical’s position as the market leader in offering the most comprehensive and innovative portfolio of rib fracture products

Passage Bio today debuted with a $115.5 million Series A financing led by OrbiMed Advisors and joined by Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital and Lilly Asia Ventures.